TNKS and cancer: Based on the observation that the inhibition of PAR formation or degradation can selectively eliminate cancer cells with specific DNA repair defects, and can enhance radiation or chemotherapy response in humans, the poly-ADP-ribose (PAR)-binding domains (PBDs) in tankyrases emerged as feasible targets for cancer therapy [130].